Antifungal activity from Ocimum gratissimum L. towards Cryptococcus neoformans

Memorias do Instituto Oswaldo Cruz

Volumn 100, Issue 1, 2005, Pages 55-58

  De Aquino Lemos, Janine ^a   Passos, Xisto Sena ^a   Lisboa Fernandes, Orionalda De Fátima ^a   De Paula, José Realino ^a   Ferri, Pedro Henrique ^a   Hasimoto E Souza, Lúcia Kioko ^a   De Aquino Lemos, Aline ^a   Rodrigues Silva, Maria Do Rosário ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Cryptococcus neoformans; Essential oil; Eugenol; Ocimum gratissimum

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTIFUNGAL AGENT; CHLOROFORM; ESSENTIAL OIL; EUGENOL; HEXANE; OCIMUM GRATISSIMUM EXTRACT;

ANTIFUNGAL ACTIVITY; ARTICLE; BASIL; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DERMATOPHYTE; DRUG INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE ISOLATION; SCREENING TEST;

ARTHRODERMATACEAE; FILOBASIDIELLA NEOFORMANS; LAMIACEAE; OCIMUM BASILICUM; OCIMUM GRATISSIMUM;

EID: 15244356739     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02762005000100011     Document Type: Article

References (24)

1. Adams RP 1995. Identification of Essential Oil Component by Chromatography/mass Spectroscopy, Allured Publishing Co., Carol Stream, Ilinois.
2. Alves SH, Cury AE 1992. Sensibilidade de leveduras do gênero Candida isoladas de pacientes com câncer, a antifúngicos poliê;nicos. Rev Inst Med Trop São Paulo 34: 251-254.
3. Alves SH, Lopes JO, Costa JM, Klock C 1997. Development of secondary resistance to fluconazole in C. neoformans isolated from a patients with AIDS. Rev Inst Med Trop São Paulo 39: 359-361.
4. Collazos J 2003. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs 17: 869-887.
5. De Bedout C, Ordónez N, Gómez BL 1999. In vitro antifungal susceptibility of clinical isolates of Cryptococcus neoformans var. neoformans and C. neoformans var. gattii. Rev Iberoam Micol 16: 36-39.
6. Dromer F, Mathoulin S, Dupont B 1996. Comparison of the efficacy of amphothericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. Clin Infect Dis 22: 154-160.
7. Dubey NK, Tiwari TN, Mandin D, Andriamboavonjy H, Chaumont JP 2000. Antifungal properties of Ocimum gratissimum essential oil (ethyl cinnamate chemotype). Fitoterapia 71: 567-569.
8. Fernandes AMAP, Prado AL, Barata LES, Paulo MQ, Azevedo NR, Ferri PH 1997. A method to separate Lignoids from Vinola leaves. Phytochemical Analysis 8: 18-21.
9. Fernandes OFL, Passos XS, Souza LKH, Miranda ATB, Cerqueira CHPV, Silva MRR 2003. In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil. Mem Inst Oswaldo Cruz 98: 839-841.
10. Larshini M, Lazrek HB, Amarouch H, Jana M 1996. Investigation of antifungal and analgesic of extracts from Sium nodiflorum. J Ethnopharmacol 53: 105-110.
11. Lima EO, Gompertz OF, Giesbrecht AM, Paulo MQ 1993. In vitro antifungal activity of essential oils obtained from officinal plants against dermatophytes. Mycoses 36: 333-336.
12. Martins AP, Salgueiro LG, Vila R, Tomi F, Cañigueral S, Casanova J, Cunha, AP, Adzet T 1999. Composition of the essential oils of O. canum, O. gratissimum and O. minimum. Planta Med 65: 187-189.
13. Mitchell GT, Perfect JR 1995. Cryptococcosis in the Era of AIDS-100 years after the discovery of Cryptococcus neoformans. J Clin Microbiol 8: 515-548.
14. Momoff M, Parrish A 2003. Fluconazole- resistant cryptococcal meningitis. S Afr Med J 93: 444.
15. Nakamura CV, Nakamura T, Bando E, Melo AFN, Cortéz, DAG, Filho BPD 1999. Antibacterial activity of Ocimum gratissimum L. essential oil. Mem Inst Oswaldo Cruz 94: 675-678.
16. Nwosu MO, Okafor J 1995. Preliminary studies of the antifungal activities of some medicinal plants against Basidiobolus and some other pathogenic fungi. Mycoses 8: 191-195.
17. Passos XS, Castro AC, Pires JS, Garcia ACF, Campos FC, Fernandes OFL, Paula JR, Ferreira HD, Santos SC, Ferri PH, Silva MRR 2003. Composition and antifungal activity of the essential oils of Caryocar brasiliensis. Pharm Biology 41: 321-326.
18. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE 2000. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 30: 710-718.
19. Souza LKH, Oliveira CMA, Ferri PH, Santos SC, Oliveira Jr JG, Miranda ATB, Liao LM, Silva MRR 2002. Antifungal properties of Brazilian Cerrado plants. Braz J Microbiol 33: 247-249.
20. Steinmetz MD, Rascol JP, Régli P, Gargadennec A, Andary C 1995. In vitro antifungal of Polyporaceae against yeasts and dermatophytes. Mycoses 38: 305-309.
21. Terrel CL 1999. Antifungal agents. Part II. The azoles. Mayo Cli Proc 100: 74-78.
22. Van Den Doll H, Kratz PDJA 1963. Generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography. J Chromatogr 11: 463-471.
23. Vasconcelos-Silva MG, Craveiro AA, Abreu Matos FJ, Machado MIL, Alencar JW 1999. Chemical variation during daytime of constituents of the essential oil of Ocimum gratissimum leaves. Fitoterapia 70: 32-34.
24. Vincenzi M, Silano M, Maialetti f, Scazzocchio B 2000. Constituents of aromatic plants: II Estragole. Fitoterapia 71: 725-729.